CNMD

CONMED Corp

NYSE · Electromedical & Electrotherapeutic Apparatus · Inc. DE · CIK 0000816956
$34.77 +1.05% $1.0B
19 New Institutional Positions8 Institutional Exits
Vol
Market Cap$1.0B
Cap SizeSmall Cap
Analyst ConsensusSell (0%)
Inst. Holders50 funds
Inst. Value$954.8M
Inst. Activity19 buys / 8 sells
SEC Reports3
Exchange NYSE·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0000816956·Prev Close $34.41

Recent Activity

Jun 2, 2026 Insider
Schwarzentraub Barbara J acquired via exercise 668 shares
Director
Jun 2, 2026 Insider
Kaye Mark acquired via exercise 668 shares
Director
Jun 2, 2026 Insider
Farkas Charles acquired via exercise 668 shares
Director
Jun 1, 2026 SEC
CONMED entered into a $450 million incremental senior secured delayed draw term loan facility (Term A-2) to repurchase a
8-K — Impact 6/10
May 20, 2026 SEC
CONMED filed a routine 8-K reporting the appointment of two new independent directors (Celine Martin and Jeff Mirviss),
8-K — Impact 3/10
Apr 7, 2026 SEC
This DEFA14A filing is a definitive proxy statement for CONMED Corp's 2026 annual meeting, detailing proposals for the e
DEFA14A — Impact 3/10
Inst.
BANK OF AMERICA CORP — ADD
1,402,620 shares ($49.6M)
Inst.
SILVERCREST ASSET MANAGEMENT GROUP — TRIM
648,577 shares ($22.9M)

Price Targets

$39.60 +13.9% upside Buy
Current $34.77 Low $39.00 Median $40.00 High $40.00 5 analysts
$39.00 $40.00

Analyst Ratings

Strong Sell0% buy · 11 analysts
0Strong Buy
0Buy
8Hold
1Sell
2Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 18, 2026 B of A Securities MAINTAIN Neutral → Neutral
May 1, 2026 Wells Fargo MAINTAIN Equal-Weight → Equal-Weight
Apr 30, 2026 JP Morgan MAINTAIN Neutral → Neutral
Mar 17, 2026 Piper Sandler DOWNGRADE Overweight → Neutral
Jan 29, 2026 Wells Fargo MAINTAIN Equal-Weight → Equal-Weight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $1.11 $1.07 — $1.12 -4% YoY 6
Next Q $1.04 $1.02 — $1.07 -4% YoY 6
Current FY $4.37 $4.30 — $4.40 -5% YoY 6
Next FY $4.79 ▼ -1.2% $4.67 — $4.98 10% YoY 6

Latest Reports

MIXED 8-K 6/10
CONMED entered into a $450 million incremental senior secured delayed draw term loan facility (Term A-2) to repurchase a
Jun 1, 2026
NEUTRAL 8-K 3/10
CONMED filed a routine 8-K reporting the appointment of two new independent directors (Celine Martin and Jeff Mirviss),
May 20, 2026

Top Institutional Holders

FundValueMove
BlackRock, Inc.$170.6M—
EARNEST PARTNERS LLC$90.9M—
VANGUARD PORTFOLIO MANAGEMENT LLC$73.4M—
FULLER & THALER ASSET$58.1M—
BANK OF AMERICA CORP$49.6MADD

Recent Insider Trades

DateInsiderTypeValue
Jun 2, 2026Schwarzentraub BarbaraM$0.00
Jun 2, 2026Kaye MarkM$0.00
Jun 2, 2026Farkas CharlesM$0.00
Jun 2, 2026Council LaVerneM$0.00
Jun 2, 2026Bronson DavidM$0.00
50 institutional holders with $954.8M total value (26,995,288 shares) as of 2026-Q1. Top holders: BlackRock,, EARNEST, VANGUARD. Net buying activity: 19 institutions added/increased vs 8 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1BlackRock, Inc.4,825,173$170.6M17.9%—
2EARNEST PARTNERS LLC2,569,653$90.9M9.5%—
3VANGUARD PORTFOLIO MANAGEMENT LLC2,076,417$73.4M7.7%—
4FULLER & THALER ASSET MANAGEMENT, INC.1,641,766$58.1M6.1%—
5BANK OF AMERICA CORP /DE/1,402,620$49.6M5.2%ADD +31.5%
6DIMENSIONAL FUND ADVISORS LP1,392,920$49.2M5.2%—
7VANGUARD CAPITAL MANAGEMENT LLC1,384,042$48.9M5.1%—
8STATE STREET CORP1,384,018$48.9M5.1%—
9SEI INVESTMENTS CO1,004,715$35.5M3.7%—
10Capital Research Global Investors925,448$32.7M3.4%—
11TWO SIGMA INVESTMENTS, LP782,540$27.7M2.9%ADD +65.3%
12SILVERCREST ASSET MANAGEMENT GROUP LLC648,577$22.9M2.4%TRIM -25.2%
13Allspring Global Investments Holdings, LLC582,733$20.7M2.2%ADD +39.9%
14CHARLES SCHWAB INVESTMENT MANAGEMENT INC478,603$16.9M1.8%—
15GOLDMAN SACHS GROUP INC476,648$16.9M1.8%—
16AMERIPRISE FINANCIAL INC460,195$16.3M1.7%DOUBLED +176.7%
17ARROWSTREET CAPITAL, LIMITED PARTNERSHIP419,092$14.8M1.6%DOUBLED +217.6%
18HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC317,450$11.2M1.2%NEW
19DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main311,469$11.0M1.2%DOUBLED +1023.1%
20Neuberger Berman Group LLC306,933$10.8M1.1%—

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
BANK OF AMERICA CORP /DE/ADD1,066,5281,402,620+31.5%$49.6M2026-Q1
SILVERCREST ASSET MANAGEMENT GROUP LLCTRIM866,775648,577-25.2%$22.9M2026-Q1
Allspring Global Investments Holdings, LLCADD416,432582,733+39.9%$20.7M2026-Q1
AMERIPRISE FINANCIAL INCDOUBLED166,300460,195+176.7%$16.3M2026-Q1
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED131,942419,092+217.6%$14.8M2026-Q1
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLCNEW—317,450—$11.2M2026-Q1
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am MainDOUBLED27,733311,469+1023.1%$11.0M2026-Q1
MORGAN STANLEYTRIM454,849291,672-35.9%$10.3M2026-Q1
GLENMEDE TRUST CO NAADD203,476275,888+35.6%$9.8M2026-Q1
Trexquant Investment LPADD136,019192,068+41.2%$6.8M2026-Q1
VOLORIDGE INVESTMENT MANAGEMENT, LLCTRIM210,193106,098-49.5%$3.8M2026-Q1
FIFTH THIRD BANCORPDOUBLED11,82270,623+497.4%$2.5M2026-Q1
Brevan Howard Capital Management LPADD26,00747,291+81.8%$1.7M2026-Q1
Universal- Beteiligungs- und Servicegesellschaft mbHDOUBLED13,92336,311+160.8%$1.3M2026-Q1
State of Tennessee, Department of TreasuryADD21,13934,145+61.5%$1.2M2026-Q1
CANADA PENSION PLAN INVESTMENT BOARDADD9,20014,800+60.9%$523.3K2026-Q1
FMR LLCDOUBLED2,29610,295+348.4%$364.0K2026-Q1
Verition Fund Management LLCTRIM13,0007,940-38.9%$280.8K2026-Q1
WEALTH ENHANCEMENT ADVISORY SERVICES, LLCDOUBLED4,4949,280+106.5%$113.7K2026-Q1
PNC FINANCIAL SERVICES GROUP, INC.ADD2,3823,085+29.5%$109.1K2026-Q1
CWM, LLCADD1,5782,014+27.6%$71.2K2026-Q1
Rockefeller Capital Management L.P.ADD1,0441,388+33.0%$49.1K2026-Q1
Freestone Grove Partners LPNEAR_EXIT11,2171,027-90.8%$36.3K2026-Q1
LOS ANGELES CAPITAL MANAGEMENT LLCNEAR_EXIT11,932169-98.6%$6.0K2026-Q1
Allworth Financial LPDOUBLED3598+180.0%$3.5K2026-Q1
14 unique insiders with 34 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 2, 2026Schwarzentraub Barbara JDirectorEXERCISE668——
Jun 2, 2026Kaye MarkDirectorEXERCISE668——
Jun 2, 2026Farkas CharlesDirectorEXERCISE668——
Jun 2, 2026Council LaVerne HDirectorEXERCISE668——
Jun 2, 2026Bronson David M.DirectorEXERCISE668——
Jun 1, 2026Schwarzentraub Barbara JDirectorAWARD5,772——
Jun 1, 2026Kaye MarkDirectorAWARD5,772——
Jun 1, 2026Farkas CharlesDirectorAWARD5,772——
Jun 1, 2026Kelderman KimDirectorAWARD5,772——
Jun 1, 2026Council LaVerne HDirectorAWARD5,772——
Jun 1, 2026Bronson David M.DirectorAWARD5,772——
Apr 1, 2026Beyer PatPresident & CEOAWARD28,145——
Mar 6, 2026Lalomia BrentExecutive VP RA, QATAX W/H26$39.90$1.0K
Mar 6, 2026Lalomia BrentExecutive VP RA, QAEXERCISE75——
Mar 2, 2026Schabacker MatthewVP GM Advanced SurgicalAWARD9,827——
Mar 2, 2026Schabacker MatthewVP GM Advanced SurgicalAWARD11,646——
Mar 2, 2026Ferrell John D.Executive Vice President - HRAWARD9,282——
Mar 2, 2026Ferrell John D.Executive Vice President - HRAWARD10,999——
Mar 2, 2026Pelletier Johonna MarieTreasurer and VP, TaxAWARD5,896——
Mar 2, 2026SHAGORY PETER KEVP, STRAT & CORP DEVTAWARD9,282——
Mar 2, 2026SHAGORY PETER KEVP, STRAT & CORP DEVTAWARD10,999——
Mar 2, 2026Lalomia BrentExecutive VP RA, QAAWARD9,554——
Mar 2, 2026Lalomia BrentExecutive VP RA, QAAWARD11,322——
Mar 2, 2026Foust Hollie KGeneral Counsel & Corp SecAWARD10,919——
Mar 2, 2026Foust Hollie KGeneral Counsel & Corp SecAWARD12,940——
Mar 2, 2026Moller Andrew JamesVP Corporate ControllerAWARD5,896——
Mar 2, 2026Beyer PatPresident & CEOAWARD28,800——
Mar 2, 2026Beyer PatPresident & CEOAWARD68,258——
Mar 2, 2026SHAGORY PETER KEVP, STRAT & CORP DEVTAWARD16,926——
Mar 2, 2026Ferrell John D.Executive Vice President - HRAWARD16,926——
Mar 2, 2026Foust Hollie KGeneral Counsel & Corp SecAWARD18,563——
Mar 2, 2026Schabacker MatthewVP GM Advanced SurgicalAWARD17,471——
Mar 2, 2026Lalomia BrentExecutive VP RA, QAAWARD17,198——
Feb 24, 2026Kaye MarkDirectorEXERCISE152——
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 2 neutral. Avg impact: 4.0/10.
MIXED 8-K 6/10
CONMED entered into a $450 million incremental senior secured delayed draw term loan facility (Term
Jun 1, 2026
NEUTRAL 8-K 3/10
CONMED filed a routine 8-K reporting the appointment of two new independent directors (Celine Martin
May 20, 2026
NEUTRAL DEFA14A 3/10
This DEFA14A filing is a definitive proxy statement for CONMED Corp's 2026 annual meeting, detailing
Apr 7, 2026
∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Sell (0% buy). Based on 11 analysts: 0 strong buy, 0 buy, 8 hold, 1 sell, 2 strong sell.

Analyst Price Targets

$39.60 mean target +13.9% upside Buy (3.00)
$39.00 Low $40.00 High
MetricValue
Current Price$34.77
Target Low$39.00
Target Mean$39.60
Target Median$40.00
Target High$40.00
# Analysts5
RecommendationBuy (3.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
 $1.11 $1.07 $1.12 -3.6% +0.3% 4↑ 1↓ $0.3B -1.4% 6
Next Q
2026-09-30
 $1.04 $1.02 $1.07 -3.7% -0.5% 2↑ 1↓ $0.3B -0.9% 6
Current FY
2026-12-31
 $4.37 $4.30 $4.40 -4.9% -0.2% 5↑ 1↓ $1.4B -0.9% 6
Next FY
2027-12-31
 $4.79 $4.67 $4.98 9.7% -1.2% 0↑ 1↓ $1.4B 5.5% 6

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$1.108
7d ago$1.105+0.003
30d ago$1.105+0.003
60d ago$1.090+0.019
90d ago$1.090+0.019
5 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 18, 2026 B of A Securities MAINTAIN Neutral Neutral
May 1, 2026 Wells Fargo MAINTAIN Equal-Weight Equal-Weight
Apr 30, 2026 JP Morgan MAINTAIN Neutral Neutral
Mar 17, 2026 Piper Sandler DOWNGRADE Overweight Neutral
Jan 29, 2026 Wells Fargo MAINTAIN Equal-Weight Equal-Weight
Jan 29, 2026 Needham REITERATE Hold Hold

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 2026008120%
May 1, 2026008120%
Apr 1, 2026008120%
Mar 1, 20262460050%
Feb 1, 20262460050%
Jan 1, 20262460050%
Strong BuyBuyHoldSellStrong Sell
∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Apr 30, 2026
short_volume
Short Volume: CNMD — 71.2% short (0.4M / 0.5M)
Short: 365,578 | Exempt: 0 | TRF Vol: 513,424 | Short Ratio: 71.2% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
earnings_calendar
CNMD Q1 2026 Earnings After Market Close — 2026-04-29
Feb 25, 2026
short_interest
FTD: CNMD — 57,556 shares ($2.7M) failed to deliver
Settlement: 20260225, Price: $46.06, FTD Value: $2,651,029.36, CONMED CORPORATION